XML 31 R5.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Net loss including noncontrolling interests $ (7,759,933) $ (5,286,646)
Other comprehensive loss:    
Foreign currency translation adjustment (26,087) 0
Comprehensive loss including noncontrolling interests (7,786,020) (5,286,646)
Comprehensive loss attributable to noncontrolling interests 11,209 0
Comprehensive loss attributable to Statera Biopharma, Inc. $ (7,774,811) $ (5,286,646)